Author Correction: The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech)

Detalles Bibliográficos
Autores principales: Andries, Jessica, Viranaicken, Wildriss, Cordonin, Colette, Herrscher, Charline, Planesse, Cynthia, Roquebert, Bénédicte, Lagrange-Xelot, Marie, El-Kalamouni, Chaker, Meilhac, Olivier, Mavingui, Patrick, Couret, David, Gadea, Gilles, Despres, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Author Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019531/
https://www.ncbi.nlm.nih.gov/pubmed/35444227
http://dx.doi.org/10.1038/s41598-022-10885-7
_version_ 1784689304486805504
author Andries, Jessica
Viranaicken, Wildriss
Cordonin, Colette
Herrscher, Charline
Planesse, Cynthia
Roquebert, Bénédicte
Lagrange-Xelot, Marie
El-Kalamouni, Chaker
Meilhac, Olivier
Mavingui, Patrick
Couret, David
Gadea, Gilles
Despres, Philippe
author_facet Andries, Jessica
Viranaicken, Wildriss
Cordonin, Colette
Herrscher, Charline
Planesse, Cynthia
Roquebert, Bénédicte
Lagrange-Xelot, Marie
El-Kalamouni, Chaker
Meilhac, Olivier
Mavingui, Patrick
Couret, David
Gadea, Gilles
Despres, Philippe
author_sort Andries, Jessica
collection PubMed
description
format Online
Article
Text
id pubmed-9019531
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-90195312022-04-20 Author Correction: The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech) Andries, Jessica Viranaicken, Wildriss Cordonin, Colette Herrscher, Charline Planesse, Cynthia Roquebert, Bénédicte Lagrange-Xelot, Marie El-Kalamouni, Chaker Meilhac, Olivier Mavingui, Patrick Couret, David Gadea, Gilles Despres, Philippe Sci Rep Author Correction Nature Publishing Group UK 2022-04-20 /pmc/articles/PMC9019531/ /pubmed/35444227 http://dx.doi.org/10.1038/s41598-022-10885-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Author Correction
Andries, Jessica
Viranaicken, Wildriss
Cordonin, Colette
Herrscher, Charline
Planesse, Cynthia
Roquebert, Bénédicte
Lagrange-Xelot, Marie
El-Kalamouni, Chaker
Meilhac, Olivier
Mavingui, Patrick
Couret, David
Gadea, Gilles
Despres, Philippe
Author Correction: The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech)
title Author Correction: The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech)
title_full Author Correction: The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech)
title_fullStr Author Correction: The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech)
title_full_unstemmed Author Correction: The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech)
title_short Author Correction: The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech)
title_sort author correction: the sars-cov-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in covid-19 mrna comirnaty vaccine (pfizer/biontech)
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019531/
https://www.ncbi.nlm.nih.gov/pubmed/35444227
http://dx.doi.org/10.1038/s41598-022-10885-7
work_keys_str_mv AT andriesjessica authorcorrectionthesarscov2spikeresidues616644and11381169delineatetwoantibodyepitopesincovid19mrnacomirnatyvaccinepfizerbiontech
AT viranaickenwildriss authorcorrectionthesarscov2spikeresidues616644and11381169delineatetwoantibodyepitopesincovid19mrnacomirnatyvaccinepfizerbiontech
AT cordonincolette authorcorrectionthesarscov2spikeresidues616644and11381169delineatetwoantibodyepitopesincovid19mrnacomirnatyvaccinepfizerbiontech
AT herrschercharline authorcorrectionthesarscov2spikeresidues616644and11381169delineatetwoantibodyepitopesincovid19mrnacomirnatyvaccinepfizerbiontech
AT planessecynthia authorcorrectionthesarscov2spikeresidues616644and11381169delineatetwoantibodyepitopesincovid19mrnacomirnatyvaccinepfizerbiontech
AT roquebertbenedicte authorcorrectionthesarscov2spikeresidues616644and11381169delineatetwoantibodyepitopesincovid19mrnacomirnatyvaccinepfizerbiontech
AT lagrangexelotmarie authorcorrectionthesarscov2spikeresidues616644and11381169delineatetwoantibodyepitopesincovid19mrnacomirnatyvaccinepfizerbiontech
AT elkalamounichaker authorcorrectionthesarscov2spikeresidues616644and11381169delineatetwoantibodyepitopesincovid19mrnacomirnatyvaccinepfizerbiontech
AT meilhacolivier authorcorrectionthesarscov2spikeresidues616644and11381169delineatetwoantibodyepitopesincovid19mrnacomirnatyvaccinepfizerbiontech
AT mavinguipatrick authorcorrectionthesarscov2spikeresidues616644and11381169delineatetwoantibodyepitopesincovid19mrnacomirnatyvaccinepfizerbiontech
AT couretdavid authorcorrectionthesarscov2spikeresidues616644and11381169delineatetwoantibodyepitopesincovid19mrnacomirnatyvaccinepfizerbiontech
AT gadeagilles authorcorrectionthesarscov2spikeresidues616644and11381169delineatetwoantibodyepitopesincovid19mrnacomirnatyvaccinepfizerbiontech
AT despresphilippe authorcorrectionthesarscov2spikeresidues616644and11381169delineatetwoantibodyepitopesincovid19mrnacomirnatyvaccinepfizerbiontech

Ejemplares similares